Table 1.
Clinical and epidemiological profile of patients with ACL with genital involvement.
| Patient | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Age in years | 41 | 47 | 65 | 43 | 27 |
| HIV | – | – | – | + | + |
| VDRL | – | – | – | – | – |
| Number of skin lesions | 54 | 44 | 55 | 3 | 52 |
| Presence of mucosal lesions in UADT | Nasal cavity, oropharynx | Nasal cavity, nasopharynx | Nasal cavity, oropharynx and larynx | Oropharynx, nasopharynx and larynx |
Oral cavity |
| Evolution time until diagnosis | 3 months | 4 months | 6 months | 6 months | 9 months |
| Residence (City) |
Rio de Janeiro | Saquarema |
Rio de Janeiro | Rio de Janeiro | Rio de Janeiro |
| Treatment | Meglumine antimoniate | Meglumine antimoniate | Liposomal amphotericin B | Liposomal amphotericin B | Meglumine antimoniate |